newsA survey of industry professionals states they expect immuno-oncology therapies…
21 January 2020 | By Hannah Balfour (European Pharmaceutical Review)
A survey of industry professionals states they expect immuno-oncology therapies and personalised medicines to continue to shape the pharmaceutical industry in the coming year.